Literature DB >> 8915141

Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease.

G J Nevitt1, P E Hutchinson.   

Abstract

The prevalence of psoriasis in a defined semi-urban general practice population of 5395 was estimated by means of a postal questionnaire, describing the features of psoriasis followed by physical examination of positive responders, and by a practice disease register, which directly identified psoriatic patients. A point prevalence of 1.48% was found based on examination at the time of study with an equal sex distribution. The mean age of development of the disease was 33 years. At the time of examination, the disease was mild in most patients (mean PASI 2.87). However, there was evidence of marked variability in severity within individuals with time. At some stage, 60% of individuals had required referral to a consultant dermatologist, and approximately 50% of these had received second-line, i.e. non-topical, treatments. Approximately 25% of patients had been in remission at some stage. Forty-one per cent of patients were aware that psoriasis was a genetically determined disease and 37% thought that stress was an exacerbating factor. Seventy per cent of patients were aware that the condition was not curable, but 63% thought that treatment was worthwhile. Fifty-three per cent described themselves as 'bothered' by the appearance of the condition. This concern was positively (and inversely) related to current age, and to stress as an exacerbating factor, but not to sex, PASI, duration of psoriasis, previous hospital referral, or the presence of pruritus. In this study of psoriasis in the community, the findings, particularly in relation to patients' attitude to the disease, disease severity, fluctuation in severity and referral requirements, are of potential interest in health care planning.

Entities:  

Mesh:

Year:  1996        PMID: 8915141

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  46 in total

1.  Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.

Authors:  R M Fernandez-Torres; S Paradela; E Fonseca
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

2.  hRDH-E2 gene polymorphisms, variable transcriptional start sites, and psoriasis.

Authors:  Yasunari Matsuzaka; Koichi Okamoto; Yoko Yoshikawa; Asumi Takaki; Akira Oka; Tomotaka Mabuchi; Mariko Iizuka; Akira Ozawa; Gen Tamiya; Jerzy K Kulski; Hidetoshi Inoko
Journal:  Mamm Genome       Date:  2004-08       Impact factor: 2.957

3.  Validity of The Health Improvement Network (THIN) for the study of psoriasis.

Authors:  N M Seminara; K Abuabara; D B Shin; S M Langan; S E Kimmel; D Margolis; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2011-02-03       Impact factor: 9.302

4.  Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.

Authors:  J Wan; J M Gelfand
Journal:  Br J Dermatol       Date:  2016-02       Impact factor: 9.302

Review 5.  Clinical and histologic diagnostic guidelines for psoriasis: a critical review.

Authors:  Mary Ann N Johnson; April W Armstrong
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

6.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

Review 7.  Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Dermatology       Date:  2016-03-25       Impact factor: 5.366

8.  Psychosomatic factors in pruritus.

Authors:  Hong Liang Tey; Joanna Wallengren; Gil Yosipovitch
Journal:  Clin Dermatol       Date:  2013 Jan-Feb       Impact factor: 3.541

9.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

10.  Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus.

Authors:  Colin D Veal; Francesca Capon; Michael H Allen; Emma K Heath; Julie C Evans; Andrew Jones; Shanta Patel; David Burden; David Tillman; Jonathan N W N Barker; Richard C Trembath
Journal:  Am J Hum Genet       Date:  2002-07-29       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.